{
    "medicine_id": "e21725c308797d29178b3111de08914aaf1dd792",
    "platform_id": "DB11256",
    "metadata": {
        "name": "Beyaz 15 mg 1 Capsule",
        "composition": "15 mg 1 Levomefolic acid",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment and prevention of folate deficiency and for use as an antidote against folic acid antagonists Contained in oral contraceptives to reduce the risk of neural tube defects arising from folic acid deficiency for pregnant women who conceived during use or shortly after the discontinuation of the product Being studied for use as a treatment for cardiovascular diseases A19273 and adjunct therapy for patients undergoing antidepressant pharmacotherapy A19271 A19272",
            "contraindications": {
                "disease": "Overdose of levomefolic acid is unlikely to cause clinically significant adverse events",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Levomefolic acid is an active metabolite of folic acid and a methyl group donor in one carbon metabolism reactions It regulates important cellular functions such as DNA biosynthesis gene expression regulation amino acid synthesis and metabolism and myelin synthesis and repair As a only form of folate that can cross the blood brain barrier it acts as a cofactor in the production of monoamine neurotransmitters such as dopamine serotonin and norepinephrine A19272 Levomefolic acid is also involved in red blood cell formation A19279",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Fosphenytoin can be decreased when it is combined with Levomefolic acid"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The therapeutic efficacy of Raltitrexed can be decreased when used in combination with Levomefolic acid"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The serum concentration of Levomefolic acid can be decreased when it is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Phenytoin can be decreased when it is combined with Levomefolic acid"
                    },
                    {
                        "drugbank-id": "DB08898",
                        "description": "The serum concentration of the active metabolites of Levomefolic acid can be reduced when Levomefolic acid is used in combination with Glucarpidase resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Primidone can be decreased when it is combined with Levomefolic acid"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The serum concentration of the active metabolites of Methylphenobarbital can be reduced when Methylphenobarbital is used in combination with Levomefolic acid resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of the active metabolites of Phenobarbital can be reduced when Phenobarbital is used in combination with Levomefolic acid resulting in a loss in efficacy"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The serum concentration of Levomefolic acid can be decreased when it is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00375",
                        "description": "The serum concentration of Levomefolic acid can be decreased when it is combined with Colestipol"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The serum concentration of Carbamazepine can be decreased when it is combined with Levomefolic acid"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01629",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with 5 fluorouridine"
                    },
                    {
                        "drugbank-id": "DB03419",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Uracil"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Tegafur"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Levomefolic acid is combined with Doxifluridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}